troglitazone has been researched along with vitamin k semiquinone radical in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Fujita, T; Fukumoto, S; Suzawa, M; Takeuchi, Y | 1 |
2 other study(ies) available for troglitazone and vitamin k semiquinone radical
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Vitamin K(2) inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures.
Topics: Adipocytes; Animals; Antineoplastic Agents; Bone and Bones; Bone Marrow Cells; Calcitriol; Calcium Channel Agonists; Carrier Proteins; Cell Differentiation; Cells, Cultured; Chromans; Gene Expression; Hemostatics; Male; Membrane Glycoproteins; Mice; Osteoclasts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone; Vitamin K; Vitamin K 2 | 2000 |